Cite
HARVARD Citation
Chow, T. et al. (2023). First‐in‐human study with SAR445088: A novel selective classical complement pathway inhibitor. Clinical and translational science. 16 (4), pp. 673-685. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chow, T. et al. (2023). First‐in‐human study with SAR445088: A novel selective classical complement pathway inhibitor. Clinical and translational science. 16 (4), pp. 673-685. [Online].